Ovarian Biopsy
Links shared publicly online about this topic
Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies - Drugs.com MedNews
drugs.com — “More than one-quarter of women with apparent early-stage ovarian cancer don t receive recommended lymph node biopsies to check for cancer spread, which nearly d” View full resource at drugs.com
Most Recently Shared on February 10, 2011 at 10:13 pm By:
Drugs and Devices OW OW Health
Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies: THURSDAY, Feb. 10 -- More th... http://bit.ly/gDvRpS #drug
Nearly 25% of women with early ovarian cancer not given recommended biopsies - USATODAY.com
usatoday.com — “More than one-quarter of women with apparent early-stage ovarian cancer don't receive recommended lymph node biopsies to check for cancer spread, which nearly doubles these patients' risk of death, say U.S. researchers.” View full resource at usatoday.com
Most Recently Shared on February 14, 2011 at 3:14 pm By:
RT @USATODAY Nearly 25% of #women with early ovarian #cancer not given recommended biopsies. http://usat.ly/fQYKpT
Nearly 25% of women with early ovarian cancer not given recommended biopsies - USATODAY.com
usatoday.com — “More than one-quarter of women with apparent early-stage ovarian cancer don't receive recommended lymph node biopsies to check for cancer spread, which nearly doubles these patients' risk of death, say U.S. researchers.” View full resource at usatoday.com
Most Recently Shared on February 12, 2011 at 6:19 pm By:
Nearly 25% of women with early ovarian cancer not given recommended biopsies http://usat.ly/ezAe3z
Ovarian Cancer and Recommended Biopsies - Cancer Information (Cancers, Symptoms, Treatment) on MedicineNet.com
medicinenet.com — “Information on many different cancers includes symptoms, cancer detection and prevention, and treatment options.” View full resource at medicinenet.com
Most Recently Shared on February 12, 2011 at 9:22 am By:
Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies: Title: Nearly 25% of Women With Ea... http://bit.ly/i6z8BV
More Than 25 Percent of U.S. Women With Ovarian Cancer Not Getting Biopsies - FoxNews.com
foxnews.com — “A new study shows that more than 25 percent of women with early-stage ovarian cancer do not have recommended lymph node biopsies to check for cancer spread, which nearly doubles the risk of death, USAToday reported” View full resource at foxnews.com
Most Recently Shared on February 14, 2011 at 2:50 pm By:
Health,Fitness,Diet Health Business
More Than 25 Percent of U.S. Women With Ovarian Cancer Not Getting Biopsies http://bit.ly/eXZ41K
More Than 25 Percent of U.S. Women With Ovarian Cancer Not Getting Biopsies - FoxNews.com
foxnews.com — “A new study shows that more than 25 percent of women with early-stage ovarian cancer do not have recommended lymph node biopsies to check for cancer spread, which nearly doubles the risk of death, USAToday reported” View full resource at foxnews.com
Most Recently Shared on February 14, 2011 at 3:31 pm By:
More Than 25 Percent of U.S. Women With Ovarian Cancer Not Getting Biopsies: A new study shows that more than 25... http://fxn.ws/g1FuYC
Many ovarian cancer patients do not get lymph node biopsies - Related Stories - ANA SmartBrief
smartbrief.com — “Data on 721 women with apparent early-stage ovarian cancer showed that only 72% of them were given biopsies to check if the cancer had metastasized in the lymph nodes of their pelvis and abdomen. The study in the Gynecological Oncology journal also found that not performing the lymph node biopsies w” View full resource at smartbrief.com
Most Recently Shared on February 11, 2011 at 5:19 pm By:
If you are a health and wellness advocate you need to read this information. http://lnkd.in/QwdiE3
Borderline Ovarian Cancer: eMedicine Obstetrics and Gynecology
emedicine.medscape.com — “Overview: Borderline ovarian tumors are a subset of epithelial ovarian tumors that have a very favorable prognosis. The accepted initial treatment is surgical removal of the tumor and biopsies. However, the postoperative management protocol is far from clear. ...” View full resource at emedicine.medscape.com
Most Recently Shared on March 10, 2010 at 8:55 pm By:
Borderline Ovarian Cancer article updated: http://bit.ly/c6VQyA.
The Utility of Peritoneal Biopsy and Omentectomy i... [Int J Gynecol Cancer. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on June 3, 2011 at 8:01 pm By:
Paul Cacciatore Patient Advocate
Study finds random peritoneal biopsies, even in early stg ovarian cancer, assist proper staging & assure proper exam. http://dld.bz/acfGN
First Blood Test for Ovarian Cancer Wins FDA Approval
healthnews.com — “On Friday September the FDA announced their approval of the first laboratory test that prior to exploratory surgery or biopsy can indicate the likelihood” View full resource at healthnews.com
Most Recently Shared on October 2, 2009 at 1:11 am By:
Matthew Zachary Patient Expert
*Progress Alert* First Blood Test for Ovarian Cancer Wins FDA Approval! http://bit.ly/bwXFk
Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA
news-medical.net — “The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.” View full resource at news-medical.net
Most Recently Shared on September 14, 2009 at 7:13 pm By:
Ovarian Cancer News: Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA: The U.S.. http://chilp.it/?e42ad1
New Drug Aims To 'Seek And Destroy' Many Types Of Cancer
sciencedaily.com — “A new drug designed to "seek and destroy" common cancers is being tested. The Phase I clinical trial is designed to evaluate the safety of EP-100 in adult patients with solid tumors whose tumor biopsies indicate that they have excessive LHRH receptors. Excessive LHRH receptors are found in a wide range of cancers, including breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers.” View full resource at sciencedaily.com
Most Recently Shared on October 15, 2009 at 1:29 pm By:
Matthew Zachary Patient Expert
The opposite of congress is progress. Now, this sounds like progress. http://bit.ly/2eUQE5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Dawn McKinney, MS/RN
RN/Nursing Educator; consultant. Interests include peds neuro & psych, including genetics. Former Navy LCDR with varied acute care experience.
-
Maureen Linke
USA TODAY Your Life, including news on health, fitness, food, parenting, family, pets, aging, sex, relationships, self-improvement and body image (web producer)
Advertisement
